Thomas F Seykora1, Laura Maggino1,2, Giuseppe Malleo2, Major K Lee1, Robert Roses1, Roberto Salvia2, Claudio Bassi1, Charles M Vollmer3. 1. Department of Surgery, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, 3400 Spruce St., Philadelphia, PA, 19104, USA. 2. Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, the Pancreas Institute, University of Verona Hospital Trust, P.le L.A. Scuro 10, 37134, Verona, Italy. 3. Department of Surgery, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, 3400 Spruce St., Philadelphia, PA, 19104, USA. charles.vollmer@uphs.upenn.edu.
Abstract
BACKGROUND: Recent data illustrates improved outcomes when adhering to early drain removal following pancreatoduodenectomy (PD). This study aims to explore the potential benefits of expanding the timeframe for early drain removal. METHODS: Six hundred forty PDs were originally managed by selective drain placement and early removal. Outcomes were reappraised in the framework of a novel proposal; intraoperative drains were omitted based on a low-risk profile (Fistula Risk Score 0-2), followed by drain removal at PODs 1, 3, and 5 if drain fluid amylase (DFA) fell below specific cutoffs based on optimized negative predictive values (NPV) for clinically relevant postoperative pancreatic fistula (CR-POPF). Characteristics of the remaining cohort with drains in situ on POD5 were examined using multivariable analysis (MVA). RESULTS: Intraoperative FRS would preclude drains from 230 (35.9%) negligible/low-risk cases with a cohort CR-POPF rate of 1.7%. Of the remaining patients, 30.5% would have drains removed on POD1 based on a DFA threshold of 300 IU/L (NPV = 98.4%), demonstrating a 1.6% CR-POPF rate. On POD3, drains could be removed in the residual cohort from 21.1% of patients with DFA ≤ 150 IU/L (NPV = 96.6%), reflecting a 3.4% CR-POPF rate. On POD5, a DFA threshold of 50 IU/L (NPV = 84%) identified 16.3% more patients whose drains could be removed. The remaining cohort (POD5 DFA > 50 IU/L), "enriched" for fistula development and reflecting just 18.4% of the original patients, displays a 61% CR-POPF rate. Among these patients on POD5, a DFA threshold > 2000 IU/L best predicted subsequent CR-POPF (PPV = 89.5%), and MVA revealed a positive association between pancreatic cancer/pancreatitis (OR = 4.37, p = 0.022) and longer operations (OR = 3.74, p = 0.014) with CR-POPF development. CONCLUSION: Early drain removal is a dynamic concept and can be employed throughout the postoperative time course using conditional thresholds to better identify patients at risk for CR-POPF.
BACKGROUND: Recent data illustrates improved outcomes when adhering to early drain removal following pancreatoduodenectomy (PD). This study aims to explore the potential benefits of expanding the timeframe for early drain removal. METHODS: Six hundred forty PDs were originally managed by selective drain placement and early removal. Outcomes were reappraised in the framework of a novel proposal; intraoperative drains were omitted based on a low-risk profile (Fistula Risk Score 0-2), followed by drain removal at PODs 1, 3, and 5 if drain fluid amylase (DFA) fell below specific cutoffs based on optimized negative predictive values (NPV) for clinically relevant postoperative pancreatic fistula (CR-POPF). Characteristics of the remaining cohort with drains in situ on POD5 were examined using multivariable analysis (MVA). RESULTS: Intraoperative FRS would preclude drains from 230 (35.9%) negligible/low-risk cases with a cohort CR-POPF rate of 1.7%. Of the remaining patients, 30.5% would have drains removed on POD1 based on a DFA threshold of 300 IU/L (NPV = 98.4%), demonstrating a 1.6% CR-POPF rate. On POD3, drains could be removed in the residual cohort from 21.1% of patients with DFA ≤ 150 IU/L (NPV = 96.6%), reflecting a 3.4% CR-POPF rate. On POD5, a DFA threshold of 50 IU/L (NPV = 84%) identified 16.3% more patients whose drains could be removed. The remaining cohort (POD5 DFA > 50 IU/L), "enriched" for fistula development and reflecting just 18.4% of the original patients, displays a 61% CR-POPF rate. Among these patients on POD5, a DFA threshold > 2000 IU/L best predicted subsequent CR-POPF (PPV = 89.5%), and MVA revealed a positive association between pancreatic cancer/pancreatitis (OR = 4.37, p = 0.022) and longer operations (OR = 3.74, p = 0.014) with CR-POPF development. CONCLUSION: Early drain removal is a dynamic concept and can be employed throughout the postoperative time course using conditional thresholds to better identify patients at risk for CR-POPF.
Entities:
Keywords:
Amylase; CR-POPF; Drain; Early removal; Fistula; Pancreatoduodenectomy
Authors: Claudio Bassi; Giovanni Marchegiani; Christos Dervenis; Micheal Sarr; Mohammad Abu Hilal; Mustapha Adham; Peter Allen; Roland Andersson; Horacio J Asbun; Marc G Besselink; Kevin Conlon; Marco Del Chiaro; Massimo Falconi; Laureano Fernandez-Cruz; Carlos Fernandez-Del Castillo; Abe Fingerhut; Helmut Friess; Dirk J Gouma; Thilo Hackert; Jakob Izbicki; Keith D Lillemoe; John P Neoptolemos; Attila Olah; Richard Schulick; Shailesh V Shrikhande; Tadahiro Takada; Kyoichi Takaori; William Traverso; Charles R Vollmer; Christopher L Wolfgang; Charles J Yeo; Roberto Salvia; Marcus Buchler Journal: Surgery Date: 2016-12-28 Impact factor: 3.982
Authors: Zhi Ven Fong; Camilo Correa-Gallego; Cristina R Ferrone; Gregory R Veillette; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-del Castillo Journal: Ann Surg Date: 2015-08 Impact factor: 12.969
Authors: Claudio Bassi; Enrico Molinari; Giuseppe Malleo; Stefano Crippa; Giovanni Butturini; Roberto Salvia; Giorgio Talamini; Paolo Pederzoli Journal: Ann Surg Date: 2010-08 Impact factor: 12.969
Authors: Matthew T McMillan; William E Fisher; George Van Buren; Amy McElhany; Mark Bloomston; Steven J Hughes; Jordan Winter; Stephen W Behrman; Nicholas J Zyromski; Vic Velanovich; Kimberly Brown; Katherine A Morgan; Charles Vollmer Journal: J Gastrointest Surg Date: 2014-09-03 Impact factor: 3.452
Authors: Brett L Ecker; Matthew T McMillan; Valentina Allegrini; Claudio Bassi; Joal D Beane; Ross M Beckman; Stephen W Behrman; Euan J Dickson; Mark P Callery; John D Christein; Jeffrey A Drebin; Robert H Hollis; Michael G House; Nigel B Jamieson; Ammar A Javed; Tara S Kent; Michael D Kluger; Stacy J Kowalsky; Laura Maggino; Giuseppe Malleo; Vicente Valero; Lavanniya K P Velu; Amarra A Watkins; Christopher L Wolfgang; Amer H Zureikat; Charles M Vollmer Journal: Ann Surg Date: 2019-01 Impact factor: 12.969
Authors: M C Giglio; D R C Spalding; A Giakoustidis; A Zarzavadjian Le Bian; L R Jiao; N A Habib; M Pai Journal: Br J Surg Date: 2016-01-21 Impact factor: 6.939
Authors: Joshua T Cohen; Kevin P Charpentier; Thomas J Miner; William G Cioffi; Rachel E Beard Journal: Ann Hepatobiliary Pancreat Surg Date: 2021-05-31